These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11238194)

  • 1. Inactivate the remaining p53 allele or the alternate p73? Preferential selection of the Arg72 polymorphism in cancers with recessive p53 mutants but not transdominant mutants.
    Tada M; Furuuchi K; Kaneda M; Matsumoto J; Takahashi M; Hirai A; Mitsumoto Y; Iggo RD; Moriuchi T
    Carcinogenesis; 2001 Mar; 22(3):515-7. PubMed ID: 11238194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mutation arising in Arg72 allele in the tumorigenesis and development of carcinoma of the urinary tract.
    Furihata M; Takeuchi T; Matsumoto M; Kurabayashi A; Ohtsuki Y; Terao N; Kuwahara M; Shuin T
    Clin Cancer Res; 2002 May; 8(5):1192-5. PubMed ID: 12006537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour.
    Marin MC; Jost CA; Brooks LA; Irwin MS; O'Nions J; Tidy JA; James N; McGregor JM; Harwood CA; Yulug IG; Vousden KH; Allday MJ; Gusterson B; Ikawa S; Hinds PW; Crook T; Kaelin WG
    Nat Genet; 2000 May; 25(1):47-54. PubMed ID: 10802655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour p53 mutations exhibit promoter selective dominance over wild type p53.
    Monti P; Campomenosi P; Ciribilli Y; Iannone R; Inga A; Abbondandolo A; Resnick MA; Fronza G
    Oncogene; 2002 Mar; 21(11):1641-8. PubMed ID: 11896595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P53 codon 72 polymorphism in Taiwanese breast cancer patients.
    Chen FM; Ou-Yang F; Yang SF; Tsai EM; Hou MF
    Kaohsiung J Med Sci; 2013 May; 29(5):259-64. PubMed ID: 23639512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis.
    Buller RE; Sood A; Fullenkamp C; Sorosky J; Powills K; Anderson B
    Cancer Gene Ther; 1997; 4(4):239-45. PubMed ID: 9253509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A polymorphism in the tumor suppressor p53 affects aging and longevity in mouse models.
    Zhao Y; Wu L; Yue X; Zhang C; Wang J; Li J; Sun X; Zhu Y; Feng Z; Hu W
    Elife; 2018 Mar; 7():. PubMed ID: 29557783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective loss of codon 72 proline p53 and frequent mutational inactivation of the retained arginine allele in colorectal cancer.
    Schneider-Stock R; Boltze C; Peters B; Szibor R; Landt O; Meyer F; Roessner A
    Neoplasia; 2004; 6(5):529-35. PubMed ID: 15548361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HIF-1- and wild-type p53-stimulated transcription by codon Arg175 p53 mutants with selective loss of functions.
    Blagosklonny MV; Giannakakou P; Romanova LY; Ryan KM; Vousden KH; Fojo T
    Carcinogenesis; 2001 Jun; 22(6):861-7. PubMed ID: 11375890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the p53 P72R Polymorphism on Mutant TP53 Allele Selection in Human Cancer.
    De Souza C; Madden J; Koestler DC; Minn D; Montoya DJ; Minn K; Raetz AG; Zhu Z; Xiao WW; Tahmassebi N; Kathi HR; Nelson N; Karnezis AN; Chien J
    J Natl Cancer Inst; 2021 Sep; 113(9):1246-1257. PubMed ID: 33555293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential.
    Dumont P; Leu JI; Della Pietra AC; George DL; Murphy M
    Nat Genet; 2003 Mar; 33(3):357-65. PubMed ID: 12567188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
    Hu Y; McDermott MP; Ahrendt SA
    Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The codon 72 polymorphism of p53 influences cell fate following nutrient deprivation.
    Kung CP; Liu Q; Murphy ME
    Cancer Biol Ther; 2017 Jul; 18(7):484-491. PubMed ID: 28475405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme.
    Marutani M; Tonoki H; Tada M; Takahashi M; Kashiwazaki H; Hida Y; Hamada J; Asaka M; Moriuchi T
    Cancer Res; 1999 Oct; 59(19):4765-9. PubMed ID: 10519380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic role of the codon 72 p53 single-nucleotide polymorphism in mammary tumorigenesis in a humanized mouse model.
    Gunaratna RT; Santos A; Luo L; Nagi C; Lambertz I; Spier M; Conti CJ; Fuchs-Young RS
    Oncogene; 2019 May; 38(18):3535-3550. PubMed ID: 30651598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes.
    Kung CP; Khaku S; Jennis M; Zhou Y; Murphy ME
    Mol Cancer Res; 2015 Feb; 13(2):250-62. PubMed ID: 25256710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
    Bhattacharya P; Sengupta S
    Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of p53 codon 72 arginine allele in cell survival in vitro and in the clinical outcome of patients with advanced breast cancer.
    Vannini I; Zoli W; Tesei A; Rosetti M; Sansone P; Storci G; Passardi A; Massa I; Ricci M; Gusolfino D; Fabbri F; Ulivi P; Brigliadori G; Amadori D; Bonafe M
    Tumour Biol; 2008; 29(3):145-51. PubMed ID: 18612219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant p53 R248Q but not R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells.
    Yoshikawa K; Hamada J; Tada M; Kameyama T; Nakagawa K; Suzuki Y; Ikawa M; Hassan NM; Kitagawa Y; Moriuchi T
    Biomed Res; 2010 Dec; 31(6):401-11. PubMed ID: 21187651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dominant negative activity of mutated p53 proteins].
    Dridi W; Krabchi K; Gadji M; Lavoie J; Bronsard M; Fetni R; Drouin R
    Med Sci (Paris); 2006 Mar; 22(3):301-7. PubMed ID: 16527213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.